Nakagawara A, Li Y, Izumi H, Muramori K, Inada H, Nishi M (2018) Neuroblastoma. Jpn J Clin Oncol 48(3):214–241
Chung C, Boterberg T, Lucas J, Panoff J, Valteau-Couanet D, Hero B, Bagatell R, Hill-Kayser CE (2021) Neuroblastoma. Pediatr Blood Cancer 68(Suppl 2):e28473
Article PubMed PubMed Central Google Scholar
Maris JM, Hogarty MD, Bagatell R, Cohn SL (2007) Neuroblastoma. Lancet 369(9579):2106–2120
Article PubMed CAS Google Scholar
Newman EA, Abdessalam S, Aldrink JH, Austin M, Heaton TE, Bruny J, Ehrlich P, Dasgupta R, Baertschiger RM, Lautz TB et al (2019) Update on neuroblastoma. J Pediatr Surg 54(3):383–389
Bao PP, Li K, Wu CX, Huang ZZ, Wang CF, Xiang YM, Peng P, Gong YM, Xiao XM, Zheng Y (2013) Recent incidences and trends of childhood malignant solid tumors in shanghai, 2002–2010. Zhonghua Er Ke Za Zhi 54:288–294
Morgenstern DA, Bagatell R, Cohn SL, Hogarty MD, Maris JM, Moreno L, Park JR, Pearson AD, Schleiermacher G, Valteau-Couanet D et al (2019) The challenge of defining “ultra-high-risk” neuroblastoma. Pediatr Blood Cancer 66(4):e27556
Qiu B, Matthay KK (2022) Advancing therapy for neuroblastoma. Nat Rev Clin Oncol 19(8):515–533
Article PubMed CAS Google Scholar
Zheng DJ, Krull KR, Chen Y, Diller L, Yasui Y, Leisenring W, Brouwers P, Howell R, Lai JS, Balsamo L et al (2018) Long-term psychological and educational outcomes for survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. Cancer 124(15):3220–3230
Article PubMed CAS Google Scholar
Bonfiglio F, Lasorsa VA, Aievola V, Cantalupo S, Morini M, Ardito M, Conte M, Fragola M, Eva A, Corrias MV et al (2024) Exploring the role of HLA variants in neuroblastoma susceptibility through whole exome sequencing. HLA 103(5):e15515
Article PubMed CAS Google Scholar
Zhang X, Wang B, Lin L, Zhou C, Zhu J, Wu H, He J (2024) TET3 gene rs828867 G>A polymorphism reduces neuroblastoma risk in Chinese children. Heliyon 10(6):e27988
Article PubMed PubMed Central CAS Google Scholar
Aygun N (2018) Biological and genetic features of neuroblastoma and their clinical importance. Curr Pediatr Rev 14(2):73–90
Article PubMed CAS Google Scholar
Stadler ZK, Vijai J, Thom P, Kirchhoff T, Hansen NA, Kauff ND, Robson M, Offit K (2010) Genome-wide association studies of cancer predisposition. Hematol Oncol Clin North Am 24(5):973–996
van Limpt V, Schramm A, van Lakeman A, Sluis P, Chan A, van Noesel M, Baas F, Caron H, Eggert A, Versteeg R (2004) The Phox2B homeobox gene is mutated in sporadic neuroblastomas. Oncogene 23(57):9280–9288
Raabe EH, Laudenslager M, Winter C, Wasserman N, Cole K, LaQuaglia M, Maris DJ, Mosse YP, Maris JM (2008) Prevalence and functional consequence of PHOX2B mutations in neuroblastoma. Oncogene 27(4):469–476
Article PubMed CAS Google Scholar
Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, Hammond D (1985) Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313(18):1111–1116
Article PubMed CAS Google Scholar
Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM (1984) Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224(4653):1121–1124
Article PubMed CAS Google Scholar
Diskin SJ, Hou C, Glessner JT, Attiyeh EF, Laudenslager M, Bosse K, Cole K, Mosse YP, Wood A, Lynch JE et al (2009) Copy number variation at 1q21.1 associated with neuroblastoma. Nature 459(7249):987–991
Article PubMed PubMed Central CAS Google Scholar
Maris JM, Mosse YP, Bradfield JP, Hou C, Monni S, Scott RH, Asgharzadeh S, Attiyeh EF, Diskin SJ, Laudenslager M et al (2008) Chromosome 6p22 locus associated with clinically aggressive neuroblastoma. N Engl J Med 358(24):2585–2593
Article PubMed PubMed Central CAS Google Scholar
Reshetnyak AV, Rossi P, Myasnikov AG, Sowaileh M, Mohanty J, Nourse A, Miller DJ, Lax I, Schlessinger J, Kalodimos CG (2021) Mechanism for the activation of the anaplastic lymphoma kinase receptor. Nature 600(7887):153–157
Article PubMed PubMed Central CAS Google Scholar
Peifer M, Hertwig F, Roels F, Dreidax D, Gartlgruber M, Menon R, Krämer A, Roncaioli JL, Sand F, Heuckmann JM et al (2015) Telomerase activation by genomic rearrangements in high-risk neuroblastoma. Nature 526(7575):700–704
Article PubMed PubMed Central CAS Google Scholar
Cheung NK, Zhang J, Lu C, Parker M, Bahrami A, Tickoo SK, Heguy A, Pappo AS, Federico S, Dalton J et al (2012) Association of age at diagnosis and genetic mutations in patients with neuroblastoma. JAMA 307(10):1062–1071
Article PubMed PubMed Central CAS Google Scholar
Chang X, Liu Y, Glessner J, Hou C, Qu H, Nguyen K, Sleiman P, Lee L, Diskin SJ, Maris JM et al (2022) Identification of mitochondrial DNA variants associated with risk of neuroblastoma. J Natl Cancer Inst 114(6):910–913
Article PubMed PubMed Central Google Scholar
Abdelaleem OO, Shaker OG, AbdelHafez MN, Abdelghaffar NK, Eid HM, Zaidan M, Khalefa AA, Ahmed NA, Hemeda NF, Zaki OM et al (2021) The influence of rs1859168 polymorphism on serum expression of HOTTIP and its target miR-615-3p in Egyptian patients with breast cancer. Biomolecules 11(5):733
Article PubMed PubMed Central CAS Google Scholar
Zheng Y, Zhuo Z, Xie X, Lu L, He Q, Zhong W (2020) Negative association between lncRNA HOTTIP rs3807598 C>G and Hirschsprung disease. Pharmgenomics Pers Med 13:151–156
PubMed PubMed Central CAS Google Scholar
Wang KC, Yang YW, Liu B, Sanyal A, Corces-Zimmerman R, Chen Y, Lajoie BR, Protacio A, Flynn RA, Gupta RA et al (2011) A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature 472(7341):120–124
Article PubMed PubMed Central CAS Google Scholar
Bhatlekar S, Fields JZ, Boman BM (2014) HOX genes and their role in the development of human cancers. J Mol Med (Berl) 92(8):811–823
Article PubMed CAS Google Scholar
Lv Z, Xu Q, Sun L, Wen J, Fang X, Xing C, Yuan Y (2019) Four novel polymorphisms in long non-coding RNA HOTTIP are associated with the risk and prognosis of colorectal cancer. Biosci Rep 39(5):BSR20180573
Article PubMed PubMed Central CAS Google Scholar
Hu P, Qiao O, Wang J, Li J, Jin H, Li Z, Jin Y (2017) rs1859168 A > C polymorphism regulates HOTTIP expression and reduces risk of pancreatic cancer in a Chinese population. World J Surg Oncol 15(1):155
Article PubMed PubMed Central Google Scholar
Cheng Y, Jutooru I, Chadalapaka G, Corton JC, Safe S (2015) The long non-coding RNA HOTTIP enhances pancreatic cancer cell proliferation, survival and migration. Oncotarget 6(13):10840–10852
Article PubMed PubMed Central Google Scholar
Li Z, Zhao X, Zhou Y, Liu Y, Zhou Q, Ye H, Wang Y, Zeng J, Song Y, Gao W et al (2015) The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. J Transl Med 13:84
Comments (0)